cbdMD, Inc.
YCBD · AMEX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -3% | -7.1% | 12.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 61.5% | 62.3% | 66.5% | 53.9% |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -9.9% | 2% | 4.9% | 6.1% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -19.4% | -31.2% | 0.3% | -3.4% |
| EPS Diluted | -0.21 | -1.9 | -0.22 | 1.52 |
| % Growth | 88.9% | -763.6% | -114.5% | – |
| Operating Cash Flow | -$0 | -$1 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$1 | -$0 | $0 |